Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
955 studies found for:    Open Studies | "Prostatic Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Unknown  A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
5 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
6 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
7 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
8 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
9 Recruiting 68Ga-PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Conditions: Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma
Interventions: Device: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)-HBED-CC;   Other: Laboratory Biomarker Analysis;   Device: Positron Emission Tomography
10 Recruiting Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study
Condition: Cancer of the Prostate
Intervention: Other: Magnetic Resonance Imaging
11 Recruiting Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
Condition: Prostate Cancer
Intervention: Radiation: Whole body MRI
12 Not yet recruiting Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
Conditions: Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Indomethacin
13 Recruiting Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
Condition: Metastatic Prostate Carcinoma
Intervention: Radiation: CIRT with systemic therapy arm
14 Recruiting A Phase III of Hypo- and Conventionally IG-VMAT in Patients With Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: hypofraction;   Radiation: convention
15 Not yet recruiting ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
Conditions: Prostate Cancer Metastatic;   Prostate Cancer
Interventions: Drug: ODM-201;   Other: Placebo
16 Not yet recruiting PROSTVAC in Combination With Nivolumab and/or Ipilimumab in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: PROSTVAC-V/F;   Drug: Nivolumab;   Drug: Ipilimumab
17 Recruiting Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Intervention: Device: Prostate Artery Embolization
18 Recruiting Evaluation of Clinical Usefulness of "SWITCH" Between Prednisone and Dexamethasone
Conditions: Prostate Cancer;   Castration Resistation
19 Recruiting Studies of Prognostic Factors in Castration Resistant PROState Cancer Treated With Radium-223
Conditions: Prostate Cancer;   Castration Resistant;   Radium 223
Intervention: Drug: Radium 223
20 Not yet recruiting A Safety and Pharmacokinetics Study of Niraparib Plus Apalutamide in Men With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Niraparib;   Drug: Apalutamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years